Healiva SA
PrivateLast Round
Grant
Dec 13, 2022
Total Funding Raised
$2.2M
Company Overview
Healiva SA is a biotechnology company that develops personalized, end-to-end wound care solutions integrating enzyme technology, cell therapies, and medical devices.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healiva SA Comparables
Compare Healiva SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vericel Corporation | 66% | |
| Aroa Biosurgery | 65% | |
| MiMedx Group, Inc. | 65% | |
Healiva SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 13, 2022 | ||||
| Seed | Nov 3, 2021 |
Healiva SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fondazione Agire | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2022
$32K grant received from Fondazione Agire and USI Startup Centre.
- Nov 3, 2021
$2.17M round led by Bioseutica Group
Healiva SA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Healiva SA's valuation, stock price, and market status.